sever
acut
respiratori
syndrom
sar
exhibit
high
mortal
rate
potenti
rapid
epidem
spread
addit
poorli
defin
clinic
present
known
treatment
prevent
method
collect
factor
underscor
need
earli
diagnosi
molecular
test
develop
detect
sar
coronaviru
sarscov
rna
use
real
time
revers
transcript
polymeras
chain
reaction
rtpcr
vari
level
sensit
howev
rna
amplif
method
demonstr
sensit
detect
rna
virus
therefor
develop
realtim
nucleic
acid
sequencebas
amplif
nasba
test
sarscov
number
primerbeacon
set
design
target
differ
region
sarscov
genom
test
sensit
specif
perform
assay
compar
rtpcr
assay
multitarget
realtim
nasba
applic
develop
detect
sarscov
polymeras
pol
nucleocapsid
n
gene
n
target
found
consist
sensit
pol
target
realtim
nasba
assay
demonstr
equival
sensit
compar
test
realtim
rtpcr
multitarget
realtim
nasba
assay
success
develop
sensit
detect
sarscov
novemb
first
case
sever
respiratori
diseas
emerg
guangdong
provinc
china
march
translat
worldwid
outbreak
sever
acut
respiratori
syndrom
sar
ensu
search
caus
diseas
led
identif
novel
coronaviru
ksiazek
et
al
close
follow
genom
character
viru
marra
et
al
rota
et
al
subsequ
confirm
new
sarsassoci
coronaviru
sarscov
order
nidoviral
famili
coronavirida
genu
coronaviru
fulfil
koch
postul
sar
diseas
sever
diagnost
assay
develop
respons
outbreak
determin
sensit
accur
method
earli
detect
sar
cultur
detect
live
sarscov
requir
biosafeti
level
three
facil
expertis
sever
limit
number
facil
institut
perform
addit
cell
cultur
isol
sarscov
sensit
detect
realtim
rtpcr
emeri
et
al
convers
serolog
method
shown
sensit
confirm
infect
detect
antibodi
occur
late
cours
ill
limit
efficaci
earli
detect
diseas
control
focu
earli
diagnosi
therefor
center
develop
molecularbas
assay
includ
convent
well
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
method
suggest
provid
greatest
sensit
test
within
first
week
infect
wu
et
al
studi
found
realtim
rtpcr
sensit
emeri
et
al
jiang
et
al
poon
et
al
less
like
produc
cross
contamin
sampl
compar
endpoint
rtpcr
nest
pcr
assay
also
describ
yam
et
al
jiang
et
al
carri
inher
high
risk
sampl
cross
contamin
given
low
viral
load
diseas
onset
maximum
assay
sensit
crucial
earli
sarscov
detect
nucleic
acid
sequencebas
amplif
nasba
develop
specif
detect
rna
sensit
rtpcr
detect
rna
virus
lanciotti
kerst
ginocchio
et
al
therefor
develop
realtim
nasba
sarscov
assay
evalu
comparison
realtim
rtpcr
assay
develop
center
diseas
control
cdc
emeri
et
al
high
titer
whole
genom
materi
urbani
strain
kindli
provid
dean
erdman
cdc
atlanta
ga
trizol
ten
microlitr
aliquot
transfer
ml
nuclisen
lysi
buffer
durham
nc
store
prior
extract
nt
vitro
transcrib
sarscov
rna
fragment
kindli
provid
christian
drosten
bernhardnocht
institut
tropic
medicin
bnitm
hamburg
germani
reconstitut
estim
copiesml
aliquot
store
hong
kong
frankfurt
isol
sarscov
kindli
provid
mathia
niedrig
part
european
qualiti
assur
eqa
studi
three
vietnames
sarscov
isol
kindli
provid
dean
erdman
extract
nucleic
acid
materi
human
respiratori
coronavirus
obtain
american
type
cultur
collect
manassa
va
sampl
ml
lysi
buffer
extract
nuclisen
extractor
accord
manufactur
instruct
yield
approxim
eluat
volum
ml
ml
total
nucleic
acid
use
per
amplif
reaction
multipl
upstream
downstream
primer
target
sarscov
urbani
strain
polymeras
gene
pol
nucleocapsid
n
leader
l
noncod
ncr
region
along
correspond
beacon
label
quench
dabcyl
design
realtim
detect
sarscov
rna
tabl
differ
combin
concentr
primer
test
optim
assay
use
nuclisen
basic
kit
reagent
accord
manufactur
instruct
briefli
reagent
sphere
dissolv
diluent
kcl
mm
final
concentr
water
ad
primer
beacon
ad
provid
final
optim
concentr
mm
respect
five
microlitr
nucleic
acid
ad
ml
reagent
mix
incub
min
min
five
microlitr
reconstitut
enzym
ad
sampl
transfer
nuclisen
easyq
analyz
isotherm
realtim
nasba
reaction
continu
min
fluoresc
measur
everi
sec
primer
contain
rna
polymeras
promot
sequenc
lower
case
stem
sequenc
molecular
beacon
also
shown
lower
case
realtim
rtpcr
perform
first
gener
primerprob
set
qiagen
germantown
md
sequenc
obtain
cdc
target
sarscov
polymeras
gene
see
tabl
ii
accord
protocol
ml
sampl
ad
mix
contain
final
concentr
rtpcr
reaction
mix
invitrogen
carlsbad
ca
mm
mgso
nm
forward
revers
primer
nm
fam
label
taqman
probe
quench
tamra
u
ssrttaq
invitrogen
carlsbad
ca
initi
primer
probe
titrat
perform
confirm
primerprob
concentr
result
shown
cycl
condit
follow
min
min
follow
sec
min
reaction
carri
abi
prism
appli
biosystem
foster
citi
ca
second
gener
multitarget
assay
kindli
provid
dean
erdman
cdc
atlanta
includ
ntarget
primerprob
set
see
tabl
ii
emeri
et
al
carri
direct
cdc
taqman
onestep
rtpcr
master
mix
reagent
appli
biosystem
foster
citi
ca
follow
condit
min
min
follow
sec
min
molecular
test
sarscov
develop
use
realtim
nasba
compar
realtim
rtpcr
assay
develop
cdc
first
gener
pol
nasba
primer
set
test
whole
genom
urbani
strain
bnitm
sarscov
transcript
well
human
respiratori
coronavirus
determin
assay
specif
data
figur
demonstr
nasbabas
test
specif
crossreact
nonsar
coronaviru
materi
wherea
urbani
bnitm
control
rna
posit
whole
blood
bronchoalveolar
lavag
bal
sampl
suspect
sar
case
present
univers
pittsburgh
medic
center
may
also
screen
assay
fig
patient
neg
sarscov
nasba
test
subsequ
shown
neg
serum
antibodi
cdc
data
shown
potenti
mutat
rate
sarscov
possibl
correspond
difficulti
viral
detect
sever
primerbeacon
set
design
target
number
differ
region
genom
set
optim
evalu
differ
combin
target
optim
primerbeacon
combin
test
dilut
seri
cultur
sarscov
rna
deriv
frankfurt
sar
index
case
fig
initi
analysi
indic
pol
primer
set
gave
greatest
sensit
follow
pol
set
defin
detect
target
highest
dilut
sarscov
rna
none
primer
set
demonstr
crossreact
clinic
relev
virus
zhang
et
al
differ
signal
amplitud
variou
target
function
individu
kinet
given
primerprob
set
interact
target
relat
sensit
sinc
assay
quantit
order
establish
neg
cutoff
assay
nine
sarscov
neg
respiratori
sampl
test
fluoresc
valu
greater
averag
neg
control
plu
four
standard
deviat
defin
posit
assay
absenc
access
abund
posit
clinic
sampl
given
inher
differ
transcript
genom
rna
test
perform
differ
nasba
primerbeacon
set
sever
sarscov
isol
coronavirus
synthes
eight
subgenom
cotermin
rna
contain
leader
sequenc
terminu
n
gene
terminu
reason
anticip
assay
target
n
gene
might
sensit
target
region
viral
genom
due
predict
abund
n
rna
transcript
sarscov
infect
cell
inde
n
primerbeacon
set
outperform
pol
set
could
consist
detect
sarscov
frequent
dilut
whole
genom
urbani
strain
rna
tabl
iii
howev
interestingli
pol
primerprob
set
equal
sensit
either
n
target
set
differ
target
set
also
use
detect
sarscov
known
copi
number
high
titer
isol
frankfurt
hong
kong
respect
similar
result
obtain
urbani
strain
data
shown
pol
n
set
show
highest
sensit
compar
l
ncr
target
detect
frankfurt
sarscov
tabl
iv
pol
n
set
therefor
character
remain
studi
order
verifi
abil
assay
detect
n
pol
target
differ
strain
sarscov
dilut
seri
vietnames
isol
earli
late
epidem
also
test
assay
target
abl
detect
strain
tabl
v
sensit
multitarget
realtim
nasba
assay
sarscov
directli
compar
three
target
realtim
rtpcr
taqman
assay
test
freshli
prepar
dilut
seri
sarscov
rna
parallel
two
multitarget
assay
appear
compar
sensit
overal
interest
differ
n
target
consist
demonstr
higher
sensit
pol
target
rtpcr
nasba
assay
n
target
more
sensit
pol
pol
addit
taqman
n
nasba
target
appear
equival
taqman
n
target
least
order
magnitud
sensit
compar
target
tabl
iii
furthermor
nasba
pol
target
sensit
taqman
sar
pol
target
two
order
magnitud
given
two
target
requir
establish
posit
either
test
appear
assay
compar
sensit
multitarget
realtim
nasba
applic
detect
sarscov
develop
shown
compar
sensit
specif
taqman
rtpcr
test
emeri
et
al
nasba
sarscov
assay
consist
detect
least
four
differ
target
six
differ
isol
demonstr
sensit
across
differ
time
geograph
locat
diseas
outbreak
n
pol
target
show
greatest
sensit
realtim
nasba
detect
sarscov
materi
test
concord
result
obtain
similar
target
cdc
taqman
test
emeri
et
al
similar
n
region
leader
sequenc
present
subgenom
rna
popul
therefor
anticip
target
might
also
provid
increas
sensit
sarscov
detect
sequenc
howev
short
effici
design
nasba
primer
set
necessit
placement
downstream
primer
outsid
leader
region
consequ
l
nasba
assay
detect
genom
rna
exhibit
lower
sensit
assay
target
n
region
clinic
test
import
determin
rna
popul
patient
sampl
sinc
could
differ
found
cultur
viru
materi
subsequ
affect
choic
sensit
sarscov
target
recent
studi
abund
n
pol
rna
transcript
viru
cultur
found
converg
day
cultur
drosten
et
al
addit
detect
n
gene
transcript
provid
greater
sensit
pol
gene
clinic
specimen
confirm
sar
patient
howev
specimen
collect
median
day
onset
symptom
studi
need
determin
n
gene
may
provid
greater
sensit
specimen
collect
earlier
day
diseas
onset
rapid
accur
detect
sarscov
major
concern
sar
outbreak
concern
continu
follow
occurr
laboratoryacquir
infect
ongo
possibl
reemerg
sar
commun
sarscov
similar
common
respiratori
influenza
virus
zoonosi
dual
tropism
respiratori
data
shown
repres
multipl
replic
experi
replic
experi
perform
duplic
dilut
point
result
record
posit
neg
duplic
valu
obtain
defin
valu
posit
neg
cutoff
nasba
describ
result
cross
signal
threshold
rtpcr
duplic
concur
result
record
either
posit
neg
case
discrep
duplic
result
record
ie
endpoint
determin
valu
duplic
consist
posit
data
shown
repres
multipl
replic
experi
gastrointestin
tissu
effici
mechan
gener
genet
variat
recur
sarscov
mutat
identifi
ruan
et
al
probabl
aros
result
passag
vero
cell
cultur
suggest
viru
fact
fairli
genet
stabl
pass
human
brown
tetro
howev
overlook
viral
replicas
error
prone
therefor
capabl
caus
rapid
unpredict
genet
chang
rest
mindel
direct
contrast
influenza
virus
viral
titer
highest
onset
diseas
viral
load
sar
initi
low
typic
peak
day
diseas
present
challeng
earli
detect
highlight
need
extrem
sensit
assay
aid
earli
diagnosi
diseas
particularli
import
given
wide
variat
clinic
present
difficulti
face
diagnos
base
symptom
date
least
three
type
diagnost
laboratori
test
avail
limit
world
health
organ
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
chen
et
al
elisa
test
reliabl
detect
antigen
week
post
onset
symptom
depend
specimen
lau
et
al
make
detect
case
difficult
time
infecti
likewis
indirect
immunofluoresc
assay
abl
detect
antibodi
reliabl
day
world
health
organ
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
culturebas
detect
requir
special
biosafeti
level
three
facil
beyond
scope
diagnost
laboratori
number
rtpcr
test
develop
simultan
evalu
yam
et
al
bressler
nolt
mahoni
et
al
detect
sarscov
rna
realtim
nasba
previous
report
literatur
advantag
realtim
nasba
assay
platform
reaction
isotherm
allow
test
rang
common
respiratori
virus
influenza
viru
human
metapneumoviru
perform
simultan
plate
assay
incub
time
also
almost
hour
shorter
rtpcr
test
allow
faster
diagnost
turnaround
time
final
case
sarscov
molecular
assay
extens
studi
need
explor
import
specimen
type
time
collect
order
achiev
maximum
reliabl
sarscov
nasba
diagnost
test
